These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 21774822)

  • 21. Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial.
    Fatemi A; Moosavi M; Sayedbonakdar Z; Farajzadegan Z; Kazemi M; Smiley A
    Clin Rheumatol; 2014 Sep; 33(9):1273-8. PubMed ID: 24820145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
    Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography (SPECT) in the detection of cardiovascular involvement in systemic lupus erythematosus patients with non-specific chest complaints.
    Sun SS; Shiau YC; Tsai SC; Lin CC; Kao A; Lee CC
    Rheumatology (Oxford); 2001 Oct; 40(10):1106-11. PubMed ID: 11600739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial Perfusion Abnormalities in Young and Premenopausal Women with Systemic Lupus Erythematosus, Detected with 99MTC MIBI Myocardial Perfusion Scintigraphy - Prevalence and Correlation with Proatherogenic Factors.
    Sandevska E; Gjorcheva DP; Vavlukis M; Sandevski A; Kafedziska I; Krstik-Damjanovska L; Majstorov V; Jovanovska-Perchinkova S; Guchev F; Kostova N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Dec; 39(2-3):79-92. PubMed ID: 30864359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
    Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternate-day versus daily atorvastatin in coronary artery disease: a randomized study.
    Rifaie O; Zahran A; Nammas W
    Anadolu Kardiyol Derg; 2012 Mar; 12(2):90-6. PubMed ID: 22281786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR; Leslie S; Stern T;
    JAMA; 2001 Apr; 285(13):1711-8. PubMed ID: 11277825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg).
    Dichtl W; Alber HF; Feuchtner GM; Hintringer F; Reinthaler M; Bartel T; Süssenbacher A; Grander W; Ulmer H; Pachinger O; Müller S
    Am J Cardiol; 2008 Sep; 102(6):743-8. PubMed ID: 18774000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
    Suleiman M; Koestler C; Lerman A; Lopez-Jimenez F; Herges R; Hodge D; Bradley D; Cha YM; Brady PA; Munger TM; Asirvatham SJ; Packer DL; Friedman PA
    Heart Rhythm; 2012 Feb; 9(2):172-8. PubMed ID: 21920481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.
    Sathyapalan T; Kilpatrick ES; Coady AM; Atkin SL
    J Clin Endocrinol Metab; 2009 Jan; 94(1):103-8. PubMed ID: 18940877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease.
    Wielepp P; Baller D; Gleichmann U; Pulawski E; Horstkotte D; Burchert W
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1371-7. PubMed ID: 16133398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter randomized trial of atorvastatin therapy in intensive care patients with severe sepsis.
    Kruger P; Bailey M; Bellomo R; Cooper DJ; Harward M; Higgins A; Howe B; Jones D; Joyce C; Kostner K; McNeil J; Nichol A; Roberts MS; Syres G; Venkatesh B;
    Am J Respir Crit Care Med; 2013 Apr; 187(7):743-50. PubMed ID: 23348980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.
    Durazzo AE; Machado FS; Ikeoka DT; De Bernoche C; Monachini MC; Puech-Leão P; Caramelli B
    J Vasc Surg; 2004 May; 39(5):967-75; discussion 975-6. PubMed ID: 15111846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD.
    Harris KP; Wheeler DC; Chong CC;
    Kidney Int; 2002 Apr; 61(4):1469-74. PubMed ID: 11918754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of atorvastatin treatment in first-degree relatives of patients with premature coronary artery disease with endothelial dysfunction: a double-blind, randomized, placebo-controlled crossover trial.
    Hong SJ; Chang HJ; Park S; Kang DR; Shin S; Cho IJ; Shim CY; Hong GR; Ha JW; Chung N
    Clin Cardiol; 2013 Aug; 36(8):480-5. PubMed ID: 23754711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
    Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals.
    Thomas MK; Narang D; Lakshmy R; Gupta R; Naik N; Maulik SK
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):37-44. PubMed ID: 16534549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.